Compare · NRGV vs TMO
NRGV vs TMO
Side-by-side comparison of Energy Vault Holdings Inc. (NRGV) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- NRGV operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $198.47B, about 332.4x NRGV ($597.1M).
- Over the past year, NRGV is up 330.9% and TMO is up 27.9% - NRGV leads by 302.9 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 7 for NRGV).
- TMO has more recent analyst coverage (25 ratings vs 12 for NRGV).
- Company
- Energy Vault Holdings Inc.
- Thermo Fisher Scientific Inc
- Price
- $3.34+1.52%
- $534.57+1.11%
- Market cap
- $597.1M
- $198.47B
- 1M return
- -24.77%
- +12.38%
- 1Y return
- +330.86%
- +27.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 7
- 9
- Recent ratings
- 12
- 25
Energy Vault Holdings Inc.
Energy Vault Holdings, Inc. develops and sells energy storage solutions. The company offers gravity-based storage systems, including EVx Platform, a scalable, modular product line starting from 40-megawatt hour to multi-gigawatt hours to address grid resiliency needs in shorter durations; Energy Vault Resiliency Center, a scalable, gigawatt hour scale product line designed to address grid resiliency needs to manage energy disruptive climate events; and Energy Vault solutions. Its solutions allow utilities, independent power producers, and large energy users to manage their power portfolios and efficiently dispatch power. Energy Vault Holdings, Inc. is based in Westlake Village, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NRGV
- Chief Financial Officer Beer Michael Thomas exercised 50,000 shares at a strike of $1.17 and sold $265,200 worth of shares (65,000 units at $4.08) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,021,806 units (SEC Form 4)
- Chief Executive Officer Piconi Robert covered exercise/tax liability with 141,682 shares, decreasing direct ownership by 0.85% to 16,449,991 units (SEC Form 4)
- Chief Operations Officer Ladwa Akshay covered exercise/tax liability with 52,721 shares, decreasing direct ownership by 2% to 2,088,615 units (SEC Form 4)
- Chief Financial Officer Beer Michael Thomas covered exercise/tax liability with 24,139 shares, decreasing direct ownership by 2% to 1,036,806 units (SEC Form 4)
- Energy Vault Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Energy Vault Joins the Russell 2000® Index
- SEC Form 4 filed by Chief Executive Officer Piconi Robert
- Citigroup initiated coverage on Energy Vault with a new price target
- Director Mandanas Mary Beth was granted 22,026 shares, increasing direct ownership by 6% to 372,864 units (SEC Form 4)
- Director Unwin Stephanie was granted 19,153 shares, increasing direct ownership by 7% to 297,245 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target